e-learning
resources
London 2016
Monday, 05.09.2016
New and old therapies for chronic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Correlation between change in lung density and lung function parameters in treated alpha-1 protease inhibitor (A1-PI) deficiency
Helmut Teschler (Essen, Germany), Helmut Teschler, Niels Seersholm, Kenneth R. Chapman, Marion Wencker, Michael Fries, Oliver Vit, N. Gerard McElvaney
Source:
International Congress 2016 – New and old therapies for chronic lung diseases
Session:
New and old therapies for chronic lung diseases
Session type:
Oral Presentation
Number:
1767
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Helmut Teschler (Essen, Germany), Helmut Teschler, Niels Seersholm, Kenneth R. Chapman, Marion Wencker, Michael Fries, Oliver Vit, N. Gerard McElvaney. Correlation between change in lung density and lung function parameters in treated alpha-1 protease inhibitor (A1-PI) deficiency. Eur Respir J 2016; 48: Suppl. 60, 1767
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Increased proportion of slow decliners in patients with alpha-1 protease inhibitor (A1-PI) deficiency following treatment with A1-PI
Source: International Congress 2016 – New and old therapies for chronic lung diseases
Year: 2016
Change in lung function and CT lung density in alpha1 antitrypsin deficiency patients under augmentation therapy
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016
Inhibition of lung inflammation by a protein epitope mimetic (PEM) neutrophil elastase inhibitor, POL6014, in a sub-chronic tobacco smoke (TS) model in mice
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013
Blood eosinophils as a biomarker in alpha 1 anti trypsin deficiency
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Synergistic effect of human tubal mesenchymal stem cell (htMSCs) and low level laser (LLL) therapy significantly reduces experimental COPD in mice
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Plant proteinase inhibitor from
crataeva tapia (CrataBl)
attenuates inflammation and remodelling induced by elastase in mice
Source: Annual Congress 2013 –Novel mechanisms in lung injury
Year: 2013
Alpha-1 antitrypsin genotypes and associated inhibitory activity towards neutrophil serine proteinases, in vivo
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015
Lung clearance index in alpha-1-antitrypsin deficiency - A follow up
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Specific airway resistance as a marker of early disease in alpha-1 antitrypsin deficiency
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015
Effect of proteinase inhibitor from
crataeva tapia
(cratabl) in distal lung mechanical, inflammatory and remodeling alterations induced by elastase in mice
Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury
Year: 2011
Anti-human heat shock protein 60 antibodies and longitudinal change in percent emphysema and lung function: The MESA lung study
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013
Relationship between plasma amino acid levels and lung function decline in patients with COPD
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
CT scan derived emphysema scores correlate with spirometry and gas exchange but not acute exacerbation rates (AER) or COPD assessment test (CAT) in COPD subjects with and without alpha-1-antitrypsin (AAT) deficiency
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
COPD: Acute exacerbation (AE) rate and saturation in the patients with different plasma surfactant protein D (SP-D) level
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Impact of bisphosphonate (BP) use on lung function decline and treatment response in patients (pts) with idiopathic pulmonary fibrosis (IPF)
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020
Relationship between asthma control test (ACT) and clinical, functional and inflammatory markers in treated and non treated asthmatics
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008
Effect of recombinant α-1 antitrypsin (rAAT) and TAPI on neutrophil elastase (NE) and matrix metalloproteinase-9 (MMP9) activity in induced sputum (IS) from healthy smokers and patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2003 - Progress on therapy for chronic obstructive pulmonary disease
Year: 2003
The effects of bronchodilators on regional lung sound distribution in patients with COPD
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013
Increased METEORIN-LIKE (ML) expression promotes lung inflammation in asthma.
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept